Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials 2021-07-19 08:30
Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay 2021-07-16 14:41
Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function 2021-07-15 21:52
ELITechGroup Acquires GONOTEC, A Leading Market Player In Freezing Point Osmometry 2021-07-15 20:00
Transcenta Announces First Patient Dosed in Global Phase I Clinical Trial of PD-L1/TGF-β Bi-functional Antibody TST005 2021-07-15 11:23
Ascentage Pharma and Innovent Biologics Reach Multifaceted Strategic Agreement Totaling US$245 Million Including Commercialization of Olverembatinib (HQP1351) in China, Joint Clinical Development of Lisaftoclax (APG-2575) and Equity Investment 2021-07-15 01:43
Deep Longevity Launches Psychological Aging Clocks and Announces Scientific Advisory Board 2021-07-14 22:35
A Drop for Clear Vision: Japan Has Surpassed Itself Again with the Development of Ultra-High-Concentration Lutein 2021-07-14 11:32
Antengene Submits New Drug Application for Selinexor in Taiwan for the Treatment of Three Indications in Hematologic Malignancies 2021-07-14 10:00
Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne 2021-07-14 07:05
UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood®- Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer' 2021-07-14 07:00
Angel Yeast Unveils New Purpose-Built Yeast and Biotechnology R&D Center 2021-07-13 22:52
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China 2021-07-13 19:47
GenScript to Host Gene & Cell Engineering Virtual Summit 2021-07-13 19:30
CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia 2021-07-13 09:06
Origin Agritech Expands GMO Trait Portfolio 2021-07-12 22:13
ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio 2021-07-12 17:00
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies 2021-07-12 17:00
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI323 (Anti-LAG-3/PD-L1 Bispecific Antibody) in Patients with Advanced Malignant Tumors 2021-07-12 08:12
Sciwind Biosciences Appoints Dr. Weidong Zhong as Chief Strategy Officer and President of its US Subsidiary 2021-07-12 08:00
1 233 234 235 236 237 451